PEGBIO CO-B (02565) announced that on November 28, 2025, the company submitted an application to the China Securities Regulatory Commission (CSRC). The application proposes to convert 102 million unlisted shares held by 20 shareholders into H shares on a one-to-one basis. These shares represent approximately 26.35% of the company's total issued shares as of the announcement date.